Login / Signup

A Prospective Evaluation of the Analytical Performance of GENECUBE® HQ SARS-CoV-2 and GENECUBE® FLU A/B.

Yoshihiko KiyasuYusaku AkashiAkio SugiyamaYuto TakeuchiShigeyuki NotakeAsami NaitoKoji NakamuraHiroichi IshikawaHiromichi Suzuki
Published in: Molecular diagnosis & therapy (2021)
The GENECUBE® HQ SARS-CoV-2 and GENECUBE® FLU A/B demonstrated sufficient analytical performance to detect SARS-CoV-2 and influenza virus A/B.
Keyphrases
  • sars cov
  • respiratory syndrome coronavirus